GNLY

GNLY
Available structures
PDBHuman UniProt search: PDBe RCSB
Identifiers
Aliases GNLY, 519, D2S69E, LAG-2, LAG2, NKG5, TLA519, granulysin
External IDs HomoloGene: 136805 GeneCards: GNLY
RNA expression pattern


More reference expression data
Orthologs
Species Human Mouse
Entrez

10578

n/a

Ensembl

ENSG00000115523

n/a

UniProt

P22749

n/a

RefSeq (mRNA)

NM_001302758
NM_006433
NM_012483

n/a

RefSeq (protein)

NP_001289687.1
NP_006424.2
NP_036615.2

n/a

Location (UCSC) Chr 2: 85.69 – 85.7 Mb n/a
PubMed search [1] n/a
Wikidata
View/Edit Human

Granulysin, also known as GNLY, is a protein which in humans is encoded by the GNLY gene.[2]

Function

Granulysin is a protein present in cytotoxic granules of cytotoxic T cells and natural killer cells. Granulysin is a member of the saposin-like protein (SAPLIP) family and is released from cytotoxic T cells upon antigen stimulation. Granulysin has antimicrobial activity against M. tuberculosis and other organisms. Granulysin is alternatively spliced, resulting in the NKG5 and 519 transcripts.[2]

Granulysin is a cytolytic and proinflammatory molecule first identified by a screen for genes expressed “late” (3–5 days) after activation of human peripheral blood mononuclear cells.[3] Granulysin is present in cytolytic granules of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Granulysin is made as a 15 kD molecule, and a portion of it is cleaved at both the amino and carboxy termini into a 9 kD form. The 9 kD form is released by receptor-mediated granule exocytosis while the 15 kD form is constitutively secreted. Recombinant 9 kD granulysin is broadly cytolytic against tumors and microbes, including gram positive and gram negative bacteria, fungi/yeast and parasites.[4] 9kD granulysin is also a chemoattractant for T lymphocytes, monocytes, and other inflammatory cells and activates the expression of a number of cytokines, including RANTES, MCP-1, MCP-3, MIP-1α, IL-10, IL-1, IL-6 and IFNα.[5] Mice do not have a granulysin homolog, but transgenic mice expressing human granulysin have been engineered.[6] Granulysin has been implicated in a myriad of diseases including infection, cancer, transplantation, autoimmunity, skin and reproductive maladies.[7]

References

  1. "Human PubMed Reference:".
  2. 1 2 "Entrez Gene: GNLY granulysin".
  3. Jongstra J, Schall TJ, Dyer BJ, Clayberger C, Jorgensen J, Davis MM, Krensky AM (March 1987). "The isolation and sequence of a novel gene from a human functional T cell line". J. Exp. Med. 165 (3): 601–14. doi:10.1084/jem.165.3.601. PMC 2188281Freely accessible. PMID 2434598.
  4. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melián A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL (October 1998). "An antimicrobial activity of cytolytic T cells mediated by granulysin". Science. 282 (5386): 121–5. doi:10.1126/science.282.5386.121. PMID 9756476.
  5. Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM (May 2005). "Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator". J. Immunol. 174 (9): 5243–8. doi:10.4049/jimmunol.174.9.5243. PMID 15843520.
  6. Huang LP, Lyu SC, Clayberger C, Krensky AM (January 2007). "Granulysin-Mediated Tumor Rejection in Transgenic Mice". J. Immunol. 178 (1): 77–84. doi:10.4049/jimmunol.178.1.77. PMC 2664664Freely accessible. PMID 17182542.
  7. Krensky AM, Clayberger C (March 2009). "Biology and clinical relevance of granulysin". Tissue Antigens. 73 (3): 193–8. doi:10.1111/j.1399-0039.2008.01218.x. PMC 2679253Freely accessible. PMID 19254247.

Further reading


This article is issued from Wikipedia - version of the 5/31/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.